Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Dujovne

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Toxicology and Applied Pharmacology|April 1, 1975
Liver cell culture toxicity and surfactant potency of erythromycin derivativesC A Dujovne
Current Opinion in Lipidology|December 31, 1997
New lipid lowering drugs and new effects of old drugsC A Dujovne
Medecine & Chirurgie Digestives|May 8, 1976
Experimental investigations on the different hepatotoxic potential of erythromycin derivativesC A Dujovne
The New England Journal of Medicine|December 4, 1980
Alterations of liver-cell membranes after exposure to halothaneC A Dujovne
Biochemical Pharmacology|January 1, 1978
Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparationsC A Dujovne
Kansas Medicine : the Journal of the Kansas Medical Society|January 1, 1985
The high risk cardiovascular patientC A Dujovne
The American Journal of Cardiology|May 15, 1997
The clinical therapeutic implications of the Scandinavian Simvastatin Survival StudyC A Dujovne
Pharmacological Research Communications|January 1, 1977
A clinical pharmacologist's view of drug hepatotoxicityC A Dujovne
The American Journal of Medicine|September 14, 1999
Middle-aged men at high risk of cardiovascular disease: the West of Scotland Coronary Prevention StudyC A Dujovne
Clinical Cardiology|February 1, 1991
Drug intervention trials in dyslipidemia: the past and the futureC A Dujovne
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Toxicology and Applied Pharmacology|April 1, 1975
Liver cell culture toxicity and surfactant potency of erythromycin derivativesC A Dujovne
Current Opinion in Lipidology|December 31, 1997
New lipid lowering drugs and new effects of old drugsC A Dujovne
Medecine & Chirurgie Digestives|May 8, 1976
Experimental investigations on the different hepatotoxic potential of erythromycin derivativesC A Dujovne
The New England Journal of Medicine|December 4, 1980
Alterations of liver-cell membranes after exposure to halothaneC A Dujovne
Biochemical Pharmacology|January 1, 1978
Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparationsC A Dujovne
Kansas Medicine : the Journal of the Kansas Medical Society|January 1, 1985
The high risk cardiovascular patientC A Dujovne
The American Journal of Cardiology|May 15, 1997
The clinical therapeutic implications of the Scandinavian Simvastatin Survival StudyC A Dujovne
Pharmacological Research Communications|January 1, 1977
A clinical pharmacologist's view of drug hepatotoxicityC A Dujovne
The American Journal of Medicine|September 14, 1999
Middle-aged men at high risk of cardiovascular disease: the West of Scotland Coronary Prevention StudyC A Dujovne
Clinical Cardiology|February 1, 1991
Drug intervention trials in dyslipidemia: the past and the futureC A Dujovne
Pageof 11